亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

濟南宏方德醫(yī)藥科技有限公司(銷售三部)  

沒有填寫主營業(yè)務(wù)~~

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:王紅
  • 電話:0531-55505896
  • QQ:2659530578
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
122111-03-9
單價 1.00 / 千克對比
銷量 暫無
發(fā)貨 山東濟南市付款后3天內(nèi)
庫存 9000千克起訂30千克
品牌 濟南宏方德
型號 122111-03-9
規(guī)格 千克
過期 長期有效
更新 2014-04-08 09:19
 
詳細信息

【中文】

***吉西他濱
【英文名稱】

2',2'-DIFLUORO-2'-DEOXYCYTIDINE
2'-DEOXY-2',2'-DIFLUOROCYTIDINE
2'-DEOXY-2',2'-DIFLUOROCYTIDINE HYDROCHLORIDE
4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride
DDFC
DFDC
DFDCYD
GEMCITABINE HCL
GEMCITABINE HYDROCHLORIDE
GEMCITABIN HYDROCHLORIDE
2’,2’-difluorodeoxycytidinemonohydrochloride
2’-deoxy-2’,2’-difluorocytidinemonohydrochloride
2’-deoxy-2’,2’-difluoro-cytidinmonohydrochloride
gemzar
ly188011
ly188011hydrochloride
GemcitabineHydrochloride&Int.
2Deoxy-22difluorocytidine Hydrochloride, dFdC, dFdCyd,
2',2'-Difluoro-2'-deoxycytidine DDFC
GEMCITABINE HYDRECHLORIDE
【CAS】

122111-03-9
【中文名稱】

4-氨基-1-(3,3-二氟-4-羥基-5-羥甲基四氫呋喃-2-基)-1H-嘧啶-2-酮***
吉西他賓***
***吉西他濱
吉西他濱***
***吉西他賓
注射用***吉西他濱
【分子式】

C9H12ClF2N3O4
【MDL 編號】

MFCD01735988
【分子量】

299.66
【MOL 文件】

122111-03-9.mol
©2025 濟南宏方德醫(yī)藥科技有限公司(銷售三部) 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7731  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |